Total Payments
$13,925
2024 Payments
$1,807
Companies
41
Transactions
677
Medicare Patients
2,426
Medicare Billing
$260,809
Payment Breakdown by Category
Food & Beverage$13,815 (99.2%)
Education$109.66 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,815 | 675 | 99.2% |
| Education | $109.66 | 2 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,351 | 135 | $0 (2022) |
| GlaxoSmithKline, LLC. | $1,707 | 86 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,546 | 60 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,274 | 55 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $948.35 | 71 | $0 (2021) |
| ABBVIE INC. | $939.99 | 74 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $609.03 | 20 | $0 (2024) |
| Amgen Inc. | $440.55 | 15 | $0 (2024) |
| UPSHER-SMITH LABORATORIES LLC | $405.92 | 20 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $392.36 | 17 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,807 | 60 | AstraZeneca Pharmaceuticals LP ($350.62) |
| 2023 | $1,324 | 52 | GlaxoSmithKline, LLC. ($259.01) |
| 2022 | $2,208 | 91 | Boehringer Ingelheim Pharmaceuticals, Inc. ($359.05) |
| 2021 | $2,751 | 142 | Novo Nordisk Inc ($633.98) |
| 2020 | $1,693 | 111 | GlaxoSmithKline, LLC. ($278.85) |
| 2019 | $1,575 | 84 | Novo Nordisk Inc ($580.23) |
| 2018 | $1,293 | 74 | Novo Nordisk Inc ($367.17) |
| 2017 | $1,274 | 63 | Novo Nordisk Inc ($326.63) |
All Payment Transactions
677 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.07 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $7.29 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Cardio-renal | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.89 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $29.82 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: PAIN | ||||||
| 10/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.46 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $24.91 | General |
| 10/14/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Diabetes Care | ||||||
| 10/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.03 | General |
| Category: NEUROSCIENCE | ||||||
| 09/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.83 | General |
| Category: NEUROSCIENCE | ||||||
| 09/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.36 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: PAIN | ||||||
| 09/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: Cardio-renal | ||||||
| 08/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.48 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $25.31 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.40 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $7.80 | General |
| Category: RESPIRATORY | ||||||
| 08/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: PAIN | ||||||
| 07/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.02 | General |
| Category: RESPIRATORY | ||||||
| 07/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.01 | General |
| Category: RESPIRATORY | ||||||
| 07/26/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $120.30 | General |
| Category: Coronary | ||||||
| 07/22/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $21.62 | General |
| 07/16/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $28.95 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 643 | 1,161 | $126,493 | $74,238 |
| 2022 | 15 | 626 | 1,137 | $125,923 | $74,205 |
| 2021 | 14 | 587 | 1,072 | $109,752 | $64,772 |
| 2020 | 16 | 570 | 1,064 | $85,506 | $47,593 |
Total Patients
2,426
Total Services
4,434
Medicare Billing
$260,809
Procedure Codes
60
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 109 | 455 | $56,875 | $35,316 | 62.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 75 | 93 | $22,746 | $14,429 | 63.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 69 | 105 | $18,900 | $11,627 | 61.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 60 | 62 | $2,790 | $2,305 | 82.6% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 63 | 65 | $3,250 | $2,051 | 63.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 33 | 43 | $3,182 | $1,695 | 53.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,300 | $1,415 | 42.9% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2023 | 15 | 15 | $1,500 | $1,408 | 93.9% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 25 | 27 | $5,400 | $1,125 | 20.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 59 | 94 | $3,290 | $894.88 | 27.2% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 20 | 29 | $1,595 | $702.50 | 44.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 26 | 34 | $1,700 | $446.08 | 26.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 13 | 13 | $455.00 | $445.90 | 98.0% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 32 | 72 | $1,080 | $231.12 | 21.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 33 | 43 | $430.00 | $146.63 | 34.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 112 | 385 | $48,125 | $31,486 | 65.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 78 | 147 | $26,460 | $16,293 | 61.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 62 | 77 | $18,172 | $11,158 | 61.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 44 | 59 | $4,366 | $2,714 | 62.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 62 | 65 | $2,885 | $2,418 | 83.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 12 | 12 | $4,200 | $2,338 | 55.7% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2022 | 63 | 66 | $3,300 | $1,972 | 59.7% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 28 | 32 | $6,400 | $1,660 | 25.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 14 | 15 | $3,000 | $1,252 | 41.7% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 37 | 87 | $3,045 | $828.34 | 27.2% |
About Dr. Marni Friedman, M.D
Dr. Marni Friedman, M.D is a Family Medicine healthcare provider based in Hollister, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477647121.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marni Friedman, M.D has received a total of $13,925 in payments from pharmaceutical and medical device companies, with $1,807 received in 2024. These payments were reported across 677 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($13,815).
As a Medicare-enrolled provider, Friedman has provided services to 2,426 Medicare beneficiaries, totaling 4,434 services with total Medicare billing of $260,809. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Hollister, CA
- Active Since 10/03/2006
- Last Updated 07/08/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1477647121
Products in Payments
- Ozempic (Drug) $1,408
- JARDIANCE (Drug) $1,037
- TRELEGY ELLIPTA (Drug) $962.74
- XARELTO (Drug) $822.81
- FARXIGA (Drug) $811.15
- VRAYLAR (Drug) $790.93
- Kerendia (Drug) $609.03
- Victoza (Drug) $432.49
- NURTEC ODT (Drug) $336.87
- UBRELVY (Drug) $329.13
- TRULICITY (Drug) $276.43
- ANORO ELLIPTA (Drug) $271.60
- AIRSUPRA (Drug) $259.40
- RYBELSUS (Drug) $255.46
- TOSYMRA (Drug) $245.81
- ENTRESTO (Drug) $241.98
- Otezla (Drug) $238.48
- STIOLTO RESPIMAT (Drug) $225.70
- Tresiba (Drug) $220.96
- FREESTYLE LIBRE 3 (Device) $207.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Hollister
Daniel Wang
Family Medicine — Payments: $33,027
Family Medicine $33,027
Marie Claudette Grageda, Md, MD
Family Medicine — Payments: $14,695
Family Medicine $14,695
Peter Coelho, M.d, M.D
Family Medicine — Payments: $8,581
Family Medicine $8,581
Arminda Tolentino, M.d, M.D
Family Medicine — Payments: $1,358
Family Medicine $1,358
Dr. Kevin Herrick, Md, MD
Family Medicine — Payments: $266.64
Family Medicine $266.64
Benedict Carota, Md, MD
Family Medicine — Payments: $260.18
Family Medicine $260.18